R-zacopride
Alternative Names: MD 20051B; SL 920241Latest Information Update: 22 Nov 1999
At a glance
- Originator Sanofi-Synthelabo
- Class Antiemetics; Anxiolytics; Benzamides; Gastrokinetics
- Mechanism of Action Serotonin 3 receptor antagonists; Serotonin 4 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Anxiety disorders
- Discontinued Nausea and vomiting
Most Recent Events
- 22 Nov 1999 Discontinued-II for Emesis in France (Unknown route)
- 22 Nov 1999 No-Development-Reported for Anxiety disorders in United Kingdom (Unknown route)
- 27 Aug 1999 Sanofi and Synthélabo have now merged to form Sanofi-Synthélabo